Central Serotonin and Melanocortin Pathways Regulating Energy Homeostasis
- 1 June 2003
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 994 (1) , 169-174
- https://doi.org/10.1111/j.1749-6632.2003.tb03177.x
Abstract
Abstract: It is now established that the hypothalamus is essential in coordinating endocrine, autonomic, and behavioral responses to changes in energy availability. However, the interaction of key peptides, neuropeptides, and neurotransmitters systems within the hypothalamus has yet to be delineated. Recently, we investigated the mechanisms through which central serotonergic (5‐hydroxytryptamine, 5‐HT) systems recruit leptin‐responsive hypothalamic pathways, such as the melanocortin systems, to affect energy balance. Through a combination of functional neuroanatomy, feeding, and electrophysiology studies in rodents, we found that 5‐HT drugs require functional melanocortin pathways to exert their effects on food intake. Specifically, we observed that anorectic 5‐HT drugs activate pro‐opiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus (Arc). We provide evidence that the serotonin 2C receptor (5‐HT2CR) is expressed on POMC neurons and contributes to this effect. Finally, we found that 5‐HT drug‐induced hypophagia is attenuated by pharmacological or genetic blockade of downstream melanocortin 3 and 4 receptors. We review candidate brain regions expressing melanocortin 3 and 4 receptors that play a role in energy balance. A model is presented in which activation of the melanocortin system is downstream of 5‐HT and is necessary to produce the complete anorectic effect of 5‐HT drugs. The data reviewed in this paper incorporate the central 5‐HT system to the growing list of metabolic signals that converge on melanocortin neurons in the hypothalamus.Keywords
This publication has 43 references indexed in Scilit:
- Expression of melanocortin 4 receptor mRNA in the central nervous system of the ratJournal of Comparative Neurology, 2003
- Activation of Central Melanocortin Pathways by FenfluramineScience, 2002
- Paraventricular hypothalamic α-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effectsPublished by Elsevier ,2001
- The Central Melanocortin System Can Directly Regulate Serum Insulin LevelsEndocrinology, 2000
- Characterization of the Neuroanatomical Distribution of Agouti-Related Protein Immunoreactivity in the Rhesus Monkey and the RatEndocrinology, 1999
- From Lesions to Leptin: Hypothalamic Control of Food Intake and Body WeightPublished by Elsevier ,1999
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Role of melanocortinergic neurons in feeding and the agouti obesity syndromeNature, 1997
- Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptorsNature, 1995
- Neurobiology of an anorectic drug: FenfluramineProgress in Neurobiology, 1986